⌘K

Home/Filings/4/0001209191-23-006050

4//SEC Filing

Harsh Michael 4

Accession 0001209191-23-006050

CIK 0001681682other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 8:30 PM ET

Size

5.3 KB

Accession

0001209191-23-006050

Insider Transaction Report

Form 4

Period: 2023-01-30

ENDRA Life Sciences Inc.NDRA

Director

Transactions

Award
Stock Options
2023-01-30+9,634→ 9,634 total
Exercise: $4.02Exp: 2033-01-30→ Common Stock (9,634 underlying)

Footnotes (1)

[F1]This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1

filerCIK 0001706155

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 8:30 PM ET
Size: 5.3 KB

View on SEC.gov